Skip to content

To study the effect of kantakari avaleha in kasa with investigation of total leukocyte count

Single arm clinical study to assess the effect of Kantakari Avaleha in Kasa with special reference to Total Leukocyte Count - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072072
Enrollment
50
Registered
2024-08-07
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R05- Cough

Interventions

None listed

Sponsors

Dr Abhishek Dayanand Kamane
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with acute onset of Kasa of less than two Weeks duration was included. Patients have fulfilling criteria for diagnosis of Cough, Shirshool, Parshvashol , Uroshool, Daha, Kantha Kandu , Peenasa

Exclusion criteria

Exclusion criteria: Patient of Kshataj and Kshayaj Kasa. Pregnant and lactating women Known case of Chronic obstructive Pulmonary disease, pneumonia, Bronchiectasis, lung abscess, pulmonary edema, HIV, HBsAg

Design outcomes

Primary

MeasureTime frame
To decrease the signs and symptoms of Kasa Timepoint: 21 days study with follow up on 7th, 14th,and 21st day

Secondary

MeasureTime frame
To study the adverse effect of Ayurvedic formulation, if any.Timepoint: 21 days study with follow up on 7th,14th & 21st day

Countries

India

Contacts

Public ContactDr Gauri Atmaram Mulik

LRP Ayurvedic Medical College and Hospital

gaurimohite492@gmail.com8806073556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026